Rodent selectivity data of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists, are presented and discussed as part of an overall optimization effort within this lead compound class. Although attachment of an acidic moiety to the 1-position of the indole led to an overall balanced in vitro profile, in particular reducing inhibition of the hERG channel, potency on the rat and mouse receptor worsened. These findings could be rationalized in the context of a CCR3 homology model.
Keywords: CCR3; Chemokine; Piperidine-4-yl-1H-indoles; Receptor model; Rodent selectivity; hERG.
Copyright © 2014 Elsevier Ltd. All rights reserved.